Engineered bispecific antibodies achieve broad and potent protection against multiple ebolavirus species.

Although the PRNT50 of S1 + 5 was also lower than that of 1C3 (1,648 ng/mL), the difference did not reach statistical significance ( P > 0.05) ( Figure 3 H).

also in 111,027 other papers